Inventages Venture Capital Investment Inc. logo

Inventages Venture Capital Investment Inc.

Europe, England, United Kingdom, London

Description

Inventages Venture Capital Investment Inc is an investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late venture

Investor Profile

Inventages Venture Capital Investment Inc. has made 37 investments, with 0 in the past 12 months and 65% as lead.

Stage Focus

  • Series A (32%)
  • Series B (30%)
  • Series Unknown (19%)
  • Series D (8%)
  • Series C (5%)
  • Series E (3%)
  • Private Equity (3%)

Country Focus

  • United States (49%)
  • United Kingdom (16%)
  • The Netherlands (8%)
  • Ireland (8%)
  • Germany (5%)
  • France (5%)
  • Canada (5%)
  • China (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Manufacturing
  • Food And Beverage
  • Biopharma
  • Health Diagnostics
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Inventages Venture Capital Investment Inc. frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
Fountain Healthcare Partners
North America, New York, United States, New York
Co-Investments: 1
Enterprise Ireland
Europe, Dublin, Ireland, Dublin
Co-Investments: 2
Burrill & Company
North America, California, United States, San Francisco
Co-Investments: 2
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 1
Seroba Life Sciences
Europe, Dublin, Ireland, Dublin
Co-Investments: 4
POSCO BioVentures
North America, California, United States, Carlsbad
Co-Investments: 2
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1

What are some of recent deals done by Inventages Venture Capital Investment Inc.?

Ripple Foods

Berkeley, California, United States

Ripple Foods specializes in making non-dairy milk with just as much protein as milk and half the sugar.

Food and BeverageFood ProcessingPlant-Based FoodsSustainability
Series DOct 22, 2020
Amount Raised: $55,766,652
Accera

Broomfield, Colorado, United States

Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.

BiotechnologyHealth CarePharmaceutical
Series UnknownOct 4, 2018
Amount Raised: $50,000,000
XOLUTION

Munich, Bayern, Germany

XO is a new solution, turning traditional cans into resealable cans.

Food and BeverageManufacturingPackaging Services
Series UnknownJan 11, 2016
Amount Raised: $48,875,961
Cognoptix

Marlborough, Massachusetts, United States

Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.

BiotechnologyHealth CareHealth DiagnosticsMedical DeviceTherapeutics
Series DSep 30, 2014
Amount Raised: $15,000,000
AM Pharma

Bunnik, Utrecht, The Netherlands

AM-Pharma is a biopharmaceutical company focused on the development of therapeutics to treat inflammatory and infectious diseases.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series ESep 11, 2014
Amount Raised: $15,765,614
Phagenesis

Manchester, Manchester, United Kingdom

Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.

BiotechnologyHealth CareMedical
Series BMay 22, 2013
Amount Raised: $17,000,000
Phosphate Therapeutics

Manchester, Manchester, United Kingdom

Phosphate Therapeutics is focused on the development of mineral-derived hospital pharmaceuticals.

BiotechnologyHealth CareTherapeutics
Series UnknownMar 5, 2012
Amount Raised: $13,882,682
Phagenesis

Manchester, Manchester, United Kingdom

Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.

BiotechnologyHealth CareMedical
Series BOct 4, 2011
Amount Raised: $9,309,291
MSI Methylation Sciences

Burnaby, British Columbia, Canada

MSI Methylation Sciences is a biotechnology company that develops and markets S-Adenosyl Methionine.

BiotechnologyDietary SupplementsMedicalTherapeutics
Series ASep 29, 2011
Amount Raised: $18,369,921
Shield Therapeutics

Weybridge, Surrey, United Kingdom

Shield Therapeutics is a pharmaceutical company developing and commercializing late-stage, mineral-derived pharmaceuticals.

BiotechnologyPharmaceuticalTherapeutics
Series AJun 1, 2011
Amount Raised: $11,792,453